State Street
CLOV icon

State Street’s Clover Health Investments CLOV Stock Holding History

State Street’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.3M Buy
10,180,337
+620,448
+6% +$2.11M ﹤0.01% 1803
2026
Q1 		$16.8M Buy
9,559,889
+239,706
+3% +$520K ﹤0.01% 2328
2025
Q4 		$21.9M Buy
9,320,183
+368,507
+4% +$1.01M ﹤0.01% 2219
2025
Q3 		$27.4M Buy
8,951,676
+1,444,286
+19% +$4.13M ﹤0.01% 2072
2025
Q2 		$20.9M Buy
7,507,390
+4,580,664
+157% +$15.1M ﹤0.01% 2159
2025
Q1 		$10.5M Buy
2,926,726
+128,965
+5% +$518K ﹤0.01% 2499
2024
Q4 		$8.81M Buy
2,797,761
+608,381
+28% +$2.17M ﹤0.01% 2701
2024
Q3 		$6.17M Buy
2,189,380
+862,621
+65% +$1.97M ﹤0.01% 2862
2024
Q2 		$1.63M Sell
1,326,759
-900,788
-40% -$808K ﹤0.01% 3382
2024
Q1 		$1.77M Sell
2,227,547
-415,562
-16% -$378K ﹤0.01% 3318
2023
Q4 		$2.52M Sell
2,643,109
-369,463
-12% -$363K ﹤0.01% 3240
2023
Q3 		$3.25M Buy
3,012,572
+1,005,375
+50% +$1.2M ﹤0.01% 3125
2023
Q2 		$1.8M Sell
2,007,197
-6,805,889
-77% -$6.04M ﹤0.01% 3445
2023
Q1 		$7.45M Sell
8,813,086
-30,826
-0.3% -$33.7K ﹤0.01% 2815
2022
Q4 		$8.22M Buy
8,843,912
+688,117
+8% +$918K ﹤0.01% 2821
2022
Q3 		$13.9M Buy
8,155,795
+205,043
+3% +$537K ﹤0.01% 2507
2022
Q2 		$17M Buy
7,950,752
+6,018,018
+311% +$16M ﹤0.01% 2368
2022
Q1 		$6.86M Buy
1,932,734
+142,690
+8% +$414K ﹤0.01% 3026
2021
Q4 		$6.66M Buy
1,790,044
+521,835
+41% +$3.2M ﹤0.01% 3111
2021
Q3 		$9.37M Buy
1,268,209
+469,870
+59% +$4.02M ﹤0.01% 2923
2021
Q2 		$10.6M Buy
798,339
+725,739
+1,000% +$7.13M ﹤0.01% 2888
2021
Q1 		$549K Buy
+72,600
New +$819K ﹤0.01% 3723

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street's CLOV Position: Q2 2026 in Review

State Street increased its Clover Health Investments (CLOV) stake by 6.5% in Q2 2026, buying an estimated $2.11M and bringing the position to 10,180,337 shares worth $53.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

State Street first reported a position in CLOV in Q1 2021 and has held it in 22 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • State Street held 10,180,337 shares of Clover Health Investments worth $53.3M as of Q2 2026.
  • State Street bought 620,448 Clover Health Investments shares in Q2 2026, an estimated $2.11M.
  • Clover Health Investments made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1803 holding.
  • State Street first reported a position in Clover Health Investments in Q1 2021 and has held it in 22 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.